• Make History at BIO 2018

    As we near the end of 2017, I’d like to take a moment to reflect on what an exciting time it’s been for the biotechnology and pharmaceutical industry. It’s an important time to celebrate and highlight exciting innovations…and how we are making history every day.
    Twenty-five years ago, a small group of visionary scientists met in a hotel room to talk about the vast potential of biotechnology to change the world as they knew it. From those talks, BIO was born. Today, our f
  • ICYMI: Jim Greenwood Weighs In on the Future of Drug Pricing

    Rewarding for quality – not quantity – is becoming more and more common in health care. Providers are being compensated for services that reflect the benefits they provide and this “patients-first” model is seeing tremendous success across the industry.
    In an opinion piece featured in The Hill, Jim Greenwood, BIO’s President and CEO discussed the need for expanding the use and feasibility of a value-based arrangement for medicines:
    “Doctors and hospitals are i
  • GMO Safety Factor Prevents Fruitful Interbreeding in the Wild

    Biotechnologists have engineered a genetic barrier to sexual reproduction between otherwise compatible populations. The barrier is called synthetic incompatibility. It depends on programmable transcription factors and works something like a kill switch, one slipped into the genetic code of a sexually reproducing organism. When the organism produces hybrid offspring, this kill switch may activate genes that cause the offspring to die.This synthetic incompatibility has been developed by scientists
  • Scientists Generate 3D Map of Gut Microbiome

    Scientists have generated a rudimentary map of the human gut microbiome, which shows the spatial organization of different microbial species. The studies are the first to examine the three-dimensional landscape of gut microorganisms, according to researchers at the Forsyth Institute in Cambridge, MA, who led the research. “No one has looked at a complex microbial community in the gut this way before,” says Gary Borisy, Ph.D., a senior research investigator at the Foryth Institute. Th
  • Advertisement

  • Nestlé Health Science, Codexis to Develop PKU Enzyme in Protein Platform Partnership

    Nestlé Health Science will use Codexis’ CodeEvolver ® protein engineering platform through a multiproject partnership that includes Nestlé gaining an option for global development of Codexis’ lead biotherapeutic candidate, phenylketonuria (PKU) candidate CDX-6114, the companies said today.Using CodeEvolver—designed to enable rapid development of highly optimized proteins, custom-designed for specific applications—Nestlé Health Science aims to disc
  • Sound Off! Genes Critical for Hearing Identified

    We often take for granted the complex nature of hearing, as we just put on our headphones or turn up the radio in the car and lose ourselves in the rhythm of a good tune. Yet, within our ears and brains, a carefully orchestrated set of events interprets sound waves into something that can evoke emotion, movement, or deep contemplation. For many years, scientists have had a decent understanding of the mechanics behind hearing—at the cell biology level. However, much of molecular symphony-co
  • Sanofi to Expand Seasonal Flu Vaccine Manufacturing Site

    Sanofi said today it will carry out a €170 million ($201 million) expansion of its vaccine manufacturing site in Val-de-Reuil, France, that is intended to keep the company among leading makers of seasonal flu vaccines.The project, which includes construction of a new vaccine production facility, is designed to enable Sanofi Pasteur, the pharma giant’s global vaccines business unit, to expand its supply of VaxigripTetra ® to up to 70 countries in six continents.The new quadrivalent
  • Celebrating our Farmers on #NationalFarmersDay!

    On National Farmers Day, we celebrate the farmers and ag leaders who make our everyday life possible. While we don’t always think about how ag impacts our day to day lives, agriculture helps provide us with food, clothing, and shelter, as well as jobs. In fact, in 2015, 21 million full- and part-time jobs were related to agriculture – that’s around 11% of total U.S. employment!
    Farmers work hard to provide a safe and affordable food supply – the average farmer g
  • Advertisement

  • Biotech VC Eyes Record Year after Strong Q3

    The dollar value and number of biopharma venture capital deals continue at a potentially record clip heading into the final quarter of 2017.Investors raised $2.221 billion in 102 biotech VC deals during the third quarter, according to the most recent quarterly PwC/CB Insights MoneyTree™ Report, released Wednesday.That’s 12% less in dollars, and almost flat in number of deals, compared with the $2.516 billion in 104 deals recorded in Q3 2016. But the third quarter finished 36% higher

Follow @Biotech_News_AU on Twitter!